ATE315398T1 - Synergistische, gold und ein corticosteroid enthaltende zusammensetzungen. - Google Patents

Synergistische, gold und ein corticosteroid enthaltende zusammensetzungen.

Info

Publication number
ATE315398T1
ATE315398T1 AT97910157T AT97910157T ATE315398T1 AT E315398 T1 ATE315398 T1 AT E315398T1 AT 97910157 T AT97910157 T AT 97910157T AT 97910157 T AT97910157 T AT 97910157T AT E315398 T1 ATE315398 T1 AT E315398T1
Authority
AT
Austria
Prior art keywords
corticosteroid
compositions containing
containing gold
disorder
synergistic compositions
Prior art date
Application number
AT97910157T
Other languages
English (en)
Inventor
Richard Edward Thomas
Original Assignee
Psiron Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Psiron Ltd filed Critical Psiron Ltd
Application granted granted Critical
Publication of ATE315398T1 publication Critical patent/ATE315398T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/242—Gold; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Contacts (AREA)
  • Manufacture And Refinement Of Metals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Liquid Crystal Substances (AREA)
AT97910157T 1996-11-04 1997-11-04 Synergistische, gold und ein corticosteroid enthaltende zusammensetzungen. ATE315398T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPO3473A AUPO347396A0 (en) 1996-11-04 1996-11-04 Synergistic gold-containing compositions

Publications (1)

Publication Number Publication Date
ATE315398T1 true ATE315398T1 (de) 2006-02-15

Family

ID=3797784

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97910157T ATE315398T1 (de) 1996-11-04 1997-11-04 Synergistische, gold und ein corticosteroid enthaltende zusammensetzungen.

Country Status (12)

Country Link
US (2) US20020094973A1 (de)
EP (1) EP0954321B1 (de)
JP (1) JP2001508042A (de)
KR (1) KR100662888B1 (de)
CN (1) CN1130201C (de)
AT (1) ATE315398T1 (de)
AU (1) AUPO347396A0 (de)
CA (1) CA2270561A1 (de)
DE (1) DE69735091T2 (de)
ES (1) ES2256878T3 (de)
WO (1) WO1998019683A1 (de)
ZA (1) ZA979906B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100836893B1 (ko) * 2006-06-23 2008-06-11 (주)두비엘 콜로이드 금의 아쥬반트로의 사용
JP4491000B2 (ja) * 2007-08-17 2010-06-30 株式会社東芝 メモリシステム
JP2011246442A (ja) * 2010-04-28 2011-12-08 Rohto Pharmaceutical Co Ltd 光老化抑制剤および皮膚菲薄化抑制剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE129254T1 (de) * 1987-03-19 1995-11-15 Arthropharm Pty Ltd Antientzündungsmittel und zusammensetzungen.
US5527779A (en) * 1988-03-23 1996-06-18 Top Gold Pty Limited Topically applied gold organic complex
NZ228367A (en) * 1988-03-23 1992-02-25 Smithkline Beecham Corp Topical composition containing a gold compound for treating inflammatory conditions
US5061700A (en) * 1989-11-16 1991-10-29 Gordon Jay Dow Glyceryl acetate ointment vehicles
GB9504265D0 (en) * 1995-03-03 1995-04-19 Medeva Plc Corticosteroid-containing pharmaceutical composition

Also Published As

Publication number Publication date
EP0954321B1 (de) 2006-01-11
DE69735091D1 (de) 2006-04-06
AUPO347396A0 (en) 1996-12-05
ES2256878T3 (es) 2006-07-16
WO1998019683A1 (en) 1998-05-14
KR100662888B1 (ko) 2007-01-02
US20050267204A1 (en) 2005-12-01
EP0954321A4 (de) 2001-06-27
JP2001508042A (ja) 2001-06-19
EP0954321A1 (de) 1999-11-10
ZA979906B (en) 1998-05-25
CN1235550A (zh) 1999-11-17
CA2270561A1 (en) 1998-05-14
CN1130201C (zh) 2003-12-10
KR20000053075A (ko) 2000-08-25
US20020094973A1 (en) 2002-07-18
HK1023515A1 (en) 2000-09-15
DE69735091T2 (de) 2006-08-24

Similar Documents

Publication Publication Date Title
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
BG110703A (en) PHARMACEUTICAL COMPOSITION, INCLUDING HUMAN ANTIBODIES CONNECTING HUMAN TNF ALPHA AND HIS APPLICATION
ID29393A (id) Komposisi pengobatan kanker dan metoda penggunaan minyak-minyak esensil tanaman alamiah
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
FI972086A7 (fi) Parannetun monilääkeresistenssiaktiivisuuden omaavat uudet aminohappoj ohdokset
BR0211062A (pt) Combinações para o tratamento de distúrbios inflamatórios
UA42747C2 (uk) Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту
MX9705235A (es) Inhibidores de calpaina y/o catepsina b de oxazolidina substituida.
PT721501E (pt) Composicao farmaceutica que compreende fosfatase ou um seu derivado
ATE257386T1 (de) Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien
DE69427704D1 (de) Neue (r)-5-carbamoyl-8-fluor-3-n,n-disubstituierte-amino-3,4-dihydro-2h-1-benzopyrane
BG97068A (bg) Фармацевтичен състав и метод за постигане на терапевтичен ефект
DE69805973D1 (de) Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin-abhängigen protein kinase
ZA943744B (en) Therapeutic substituted guanidines
BG101392A (en) Method of treating diabetes mellitus using kgf
DE60040753D1 (de) Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden
DE69413829D1 (de) Antiglucocorticoidsteroide zur behandlung von angststörungen
DE69838882D1 (de) Pharmazeutisch wirksame verbindungen und methoden zu ihrer anwendung
ES2106531T3 (es) Compuestos de dibenzoxazepina substituidos en 2, 3, 4, 5, 6, 7, 8, 9 y/o 10, composiciones farmaceuticas y metodos de uso.
MXPA94009086A (es) Guanidinas sustituidas terapeuticas.
DE69825279D1 (de) Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz
ATE315398T1 (de) Synergistische, gold und ein corticosteroid enthaltende zusammensetzungen.
ATE305311T1 (de) Zusammensetzung zur behandlung von herzinsuffizienz
RU94041028A (ru) Применение производных мелатонина для лечения десинхронизационных нарушений, фармацевтическая композиция
DE69124380D1 (de) Verfahren und zusammensetzungen für die behandlung durch t-zellen vermittelter krankheiten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties